Press Release Feb 24 2026
Filed with NSE · · 3 pages · English
Shilpa Medicare Limited Corporate & Admin Office: “Shilpa House”, # 12-6-214/A-1, Hyderabad Road, Raichur – 584 135, Karnataka, India Tel: +91-8532-238704, Fax: +91-8532-238876 Email: [email protected], Web: www.vbshilpa.com CIN: L85110KA1987PLC008739 Date: 24 February 2026 Plot No.C/1, G Block Mumbai-400 001 Mumbai-400 051 Stock Code: NSE: SHILPAMED/BSE-530549 Sub: - Press Release - on licensing
Shilpa Medicare Limited on 6ix
Earlier from Shilpa Medicare
- Press Release Jan 28 2026
- Shilpa Pharma Lifesciences Awarded EcoVadis Gold Medal for Outstanding Sustainability Practices
- Shilpa Medicare Announces Positive Phase 3 Results for OERIS™ -- A Novel Once-Weekly Ondansetron Extended-Release Injection for Chemotherapy-Induced Nausea and Vomiting (CINV)
- Shilpa Medicare's NorUDCA Makes History as First Approved NAFLD Therapy Worldwide
- Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Groundbreaking Pulmonary Therapeutics
Later from Shilpa Medicare
- SteinCares and Shilpa Biologicals Strike into Licensing Agreement to Expand Access to Biosimilars Across Latin America
- Press Release Jun 03 2026
- Shilpa Medicare Limited Press Release Jun 24 2026
- Shilpa Medicare Limited Press Release Jun 30 2026
- Shilpa Medicare Limited Press Release Sep 11 2026
Follow Shilpa Medicare into a list and get an email when it puts out news.
Follow Shilpa Medicare